Omada Health, Inc.

Loan Repayment On July 31, 2025, Omada fully repaid outstanding amounts under its term loan facility and revolving line of credit, with cumulative principal and accrued interest balances of $31.0 million and $0.4 million, respectively, ahead of their contractual maturity on June 1, 2028.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

The extinguishment will reduce future interest expense and eliminate related debt covenants.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Examples of forward-looking statements contained in this press release include, but are not limited to, statements we make regarding relationship with PBMs and their pharmacy benefits coverage, GLP-1 progress, business trends, growth prospects and future financial and operating results, reduction in interest expense and elimination of debt covenants, and our financial outlook.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

We define adjusted EBITDA as net loss and comprehensive loss reported on our consolidated statements of operations, excluding the impact of interest expense, interest income, change in fair value of warrant liabilities, loss on debt extinguishment, provision for income taxes, share-based compensation expense, amortization of intangible assets, depreciation and amortization, and loss on disposal of property and equipment.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Redeemable Convertible Preferred Stock and Common Stock Warrants The Company previously issued common and redeemable convertible preferred stock warrants in connection with certain notes payable and debt financing transactions.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, macroeconomic and industry conditions and other factors.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value: Level 1 inputs: Quoted prices for identical assets and liabilities in active markets.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.

SEC original ↗Omada Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Legal Proceedings 24 Item 1A.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control), and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

These risks and uncertainties include, but are not limited to, those factors discussed in Part I, Item 2, Management s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A, Risk Factors in this Quarterly Report on Form 10-Q, as well as other documents that may be filed by us from time to time with the U.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q.

SEC original ↗Omada Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026